Paper Review Records
全部论文审稿周期
14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
336
天
195
天
At the forefront of gene-based therapies in Dravet syndrome
作者
Antonella Riva; Sara Di Gioacchino; Greta Volpedo; Beatrice Risso; Antonella De Lillo; Federico Zara; Antonio Falace; Pasquale Striano展开收起
作者单位
1. University of Genoa; 2. IRCCS Istituto “Giannina Gaslini”, Full Member of ERN EpiCARE展开收起
29
天
236
天
Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease
作者
Madia Lozupone; Vittorio Dibello; Rodolfo Sardone; Roberta Zupo; Fabio Castellana; Ilaria Bortone; Luisa Lampignano; Michela Di Matteo; Giuseppe Moramarco; Flora Dellegrazie; Antonio Daniele; Vincenzo Solfrizzi; Francesco Panza展开收起
作者单位
1. Local Health Authority of Bari; 2. University of Bari Aldo Moro; 3. University of Bari “Aldo Moro”; 4. University of Amsterdam and Vrije Universiteit Amsterdam; 5. Local Healthcare Authority of Taranto; 6. Local Healthcare Authority of Bari; 7. Catholic University of Sacred Heart; 8. IRCCS Fondazione Policlinico Universitario A. Gemelli展开收起
87
天
Obefazimod (ABX464) for moderate-to-severe Crohn’s disease: clinical development of a novel oral therapeutic approach
作者
Sailish Honap; Axel Dignass; Vipul Jairath; Fernando Magro; Silvio Danese; Laurent Peyrin-Biroulet展开收起
作者单位
1. St George’s University Hospitals NHS Foundation Trust; 2. King’s College London; 3. Goethe University; 4. Western University; 5. Faculdade de Medicina da Universidade do Porto; 6. IRCCS Ospedale San Raffaele; 7. McGill University Health Centre展开收起
77
天
FAQ
EXPERT OPINION ON EMERGING DRUGS审稿要多久?
截至2026-11-19,CrushSCI 收录了 EXPERT OPINION ON EMERGING DRUGS 的 14 篇完整审稿记录。最快一篇从收稿到录用用了 29 天(σ 1 receptor agonists: the new trend or an emerging therapeutic option?,2026-05-28 收稿,2026-06-26 录用),最慢一篇用了 420 天;平均 150.1 天,中位数 91 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
